Dr Edward Leatham

Fix the food first, then move, then build muscle — and only then reach for drugs, in a sequence chosen to shrink visceral fat and flatten the glucose curve rather than simply to satisfy a cost-effectiveness threshold.

Appetite suppression is the dominant, well-evidenced mechanism behind GLP-1 and dual GIP/GLP-1 drugs. It is probably most of the story — but a patient losing a stone in six weeks on a sub-licensed dose, with almost no dietary change, sits in the part it does not comfortably explain. The grown-up response to that gap is not to pretend, but to ask better questions. This series asks one of them.

Two people can share the same weight and BMI yet have completely different risks of heart attack and type 2 diabetes. The difference is often visceral fat — the hidden fat wrapped around your organs. This article explains what it does, why scales miss it, and how to reduce it.